{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:01:05Z","timestamp":1781546465347,"version":"3.54.5"},"reference-count":107,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T00:00:00Z","timestamp":1149638400000},"content-version":"vor","delay-in-days":1375,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drug Reviews"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>LY404187 is a selective, potent and centrally active positive allosteric modulator of AMPA receptors. LY404187 preferentially acts at recombinant human homomeric GluR2 and GluR4 versus GluR1 and GluR3 AMPA receptors. In addition, LY404187 potentiates the flip splice variant of these AMPA receptors to a greater degree than the flop splice variant. In both recombinant and native AMPA receptors, potentiation by LY404187 displays a unique time\u2010dependent growth that appears to involve a suppression of the desensitization process of these ion channels. LY404187 has been shown to enhance glutamatergic synaptic transmission both<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo.<\/jats:italic>This augmentation of synaptic activity is due to the direct potentiation of AMPA receptor function, as well as an indirect recruitment of voltage\u2010dependent NMDA receptor activity. Enhanced calcium influx through NMDA receptors is known to be a critical step in initiating long\u2010term modifications in synaptic function (e.g., long\u2010term potentiation, LTP). These modifications in synaptic function may be substrates for certain forms of memory encoding. Consistent with a recruitment of NMDA receptor activity, LY404187 has been shown to enhance performance in animal models of cognitive function requiring different mnemonic processes. These data suggest that AMPA receptor potentiators may be therapeutically beneficial for treating cognitive deficits in a variety of disorders, particularly those that are associated with reduced glutamatergic signaling such as schizophrenia. In addition, LY404187 has been demonstrated to be efficacious in animal models of behavioral despair that possess considerable predictive validity for antidepressant activity. Although the therapeutic efficacy of AMPA receptor potentiators in these and other diseases will ultimately be determined in the clinic, evidence suggests that the benefit of these compounds will be mediated by multiple mechanisms of action. These mechanisms include direct enhancement of AMPA receptor function, secondary mobilization of intracellular signaling cascades, and prolonged modulation of gene expression.<\/jats:p>","DOI":"10.1111\/j.1527-3458.2002.tb00228.x","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T20:36:04Z","timestamp":1281731764000},"page":"255-282","source":"Crossref","is-referenced-by-count":82,"title":["LY404187: A Novel Positive Allosteric Modulator of AMPA Receptors"],"prefix":"10.1111","volume":"8","author":[{"given":"Jennifer C.","family":"Quirk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Nisenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,7]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"304","volume-title":"Current issues in the psychopharmacology of schizophrenia","author":"Abi\u2010Saab W","year":"2001"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401239709147778"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb11031.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90181-8"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)91732-9"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/27692"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)00094-5"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1736359"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00916547"},{"issue":"1","key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3565(24)29355-1","article-title":"Positive modulation of alpha\u2010amino\u20103\u2010hydroxy\u20105\u2010methyl\u20104\u2010isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator","volume":"298","author":"Baumbarger PJ","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1177\/0883073891006001S02","article-title":"The role of frontal dysfunction in attention deficit hyperactivity disorder","volume":"6","author":"Benson D.","year":"1991","journal-title":"J Child Neurol"},{"issue":"11","key":"e_1_2_1_13_2","first-page":"902","article-title":"Anxiolytic activity of piracetam, a nootropic agent, following subchronic administration in rodents","volume":"31","author":"Bhattacharya SK","year":"1993","journal-title":"Indian J Exp Biol"},{"key":"e_1_2_1_14_2","first-page":"173","article-title":"Novel AMPA receptor potentiators LY392098 and LY404187: Effects on recombinant human and rat neuronal AMPA receptors","volume":"30","author":"Bleakman D","year":"2000","journal-title":"Soc Neurosci Abstr"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(00)00073-8"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2903551"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.237"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.102006401.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017318"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/10673229609017192"},{"issue":"5","key":"e_1_2_1_21_2","first-page":"241","article-title":"Some effects of piracetam (UCB 6215 Nootropil) on chronic schizophernia","volume":"3","author":"Dimond SJ","year":"1979","journal-title":"psychopharmacology"},{"issue":"1","key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine R","year":"1999","journal-title":"Pharmacol Rev"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02462899"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(94)00247-C"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(96)00195-7"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00220-X"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(79)90185-9"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000911"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0926-6410(96)00054-7"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191353298"},{"issue":"8","key":"e_1_2_1_31_2","first-page":"948","article-title":"Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors","volume":"40","author":"Gates MR","year":"2001","journal-title":"in vitro. Neuropharmacology"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90076-4"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00005"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.6.4.348"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<332::AID-SYN4>3.0.CO;2-C"},{"issue":"7","key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1523\/JNEUROSCI.18-07-02740.1998","article-title":"Facilitative effects of the ampakine CX516 on short\u2010term memory in rats: Enhancement of delayed\u2010nonmatch\u2010to\u2010sample performance","volume":"18","author":"Hampson RE","year":"1998","journal-title":"J Neurosci"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/16269"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.17.030194.000335"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1653450"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199709000-00007"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2000.7544"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6581"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1990.sp018081"},{"key":"e_1_2_1_44_2","first-page":"1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"48","author":"Javitt DC","year":"1991","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903130404"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1992.tb00154.x"},{"issue":"5","key":"e_1_2_1_47_2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0026-895X(25)10553-1","article-title":"Interactions among GYKI\u201052466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors","volume":"48","author":"Johansen TH","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"1","key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(24)38148-0","article-title":"Synergistic interactions between ampakines and antipsychotic drugs","volume":"289","author":"Johnson SA","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2166337"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051049"},{"issue":"3","key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/hrp.7.3.125","article-title":"NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders","volume":"7","author":"Krystal JH","year":"1999","journal-title":"Harvard Rev Psych"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.5.1797"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199404030-00007"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00006-5"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(00)00194-5"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.6.861b"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00013-2"},{"key":"e_1_2_1_59_2","first-page":"173","article-title":"LY392098 and LY404187 potentiate responses of rat hippocampal neurones to AMPA","volume":"30","author":"Lodge D","year":"2000","journal-title":"in vivo. Soc Neurosci Abstr"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7992055"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520370050018"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1959.02340150095011"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6447"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(93)90001-R"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90199-P"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.4.1411"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/309261a0"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(99)00044-2"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00027-2"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90176-Z"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973663"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100849"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb11320.x"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007870050049"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/307462a0"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017394"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0002836"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(97)00085-3"},{"issue":"1","key":"e_1_2_1_80_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0026-895X(25)08654-7","article-title":"Cyclothiazide differentially modulates desensitization of alpha\u2010amino\u20103\u2010hydroxy\u20105\u2010methyl\u20104\u2010isoxazolepropionic acid receptor splice variants","volume":"46","author":"Partin KM","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"21","key":"e_1_2_1_81_2","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1523\/JNEUROSCI.16-21-06634.1996","article-title":"AMPA receptor flip\/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate","volume":"16","author":"Partin KM","year":"1996","journal-title":"J Neurosci"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(85)90523-4"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(95)80168-2"},{"issue":"15","key":"e_1_2_1_84_2","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1523\/JNEUROSCI.17-15-05928.1997","article-title":"AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired","volume":"17","author":"Rogan MT","year":"1997","journal-title":"J Neurosci"},{"key":"e_1_2_1_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00747-7"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(00)00364-8"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)00179-Z"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979231"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-199501000-00014"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.12.1105"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(96)00169-4"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71062454.x"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1699275"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.2.777"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.2.777"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00388.x"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/57.1.61"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1988.tb00718.x"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00031-4"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00174514"},{"issue":"24","key":"e_1_2_1_102_2","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1523\/JNEUROSCI.17-24-09393.1997","article-title":"Differential dependence on GluR2 expression of three characteristic features of AMPA receptors","volume":"17","author":"Washburn MS","year":"1997","journal-title":"J Neurosci"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1996.0135"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.13-09-03904.1993"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1998.0190"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.4.765"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011153232001"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm000462n"}],"container-title":["CNS Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3458.2002.tb00228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3458.2002.tb00228.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:33:15Z","timestamp":1740400395000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3458.2002.tb00228.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1111\/j.1527-3458.2002.tb00228.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3458.2002.tb00228.x","archive":["Portico"],"relation":{},"ISSN":["1080-563X","1527-3458"],"issn-type":[{"value":"1080-563X","type":"print"},{"value":"1527-3458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}